Genotoxicity Assessment via RNA Expression Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing the genotoxic potential of agents in mammalian hematopoietic cells are time-consuming and provide limited insight, relying on cell growth indicators that depend on specific cultivation conditions and are not sensitive enough to detect genotoxic effects accurately.
Innovation Solution
A process involving the cultivation of hematopoietic stem and progenitor cells with the agent, followed by RNA sequencing to determine the expression levels of specific RNAs, allowing for the differentiation between immortalized and non-immortalized cells, and calculating a normalized enrichment score to assess genotoxic activity, which is independent of Lmo2 expression and requires shorter cultivation times.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell growth indicators are used to assess genotoxic potential, then the assessment can be performed, but the method is time-consuming and provides limited insight
Solution Approach 1:
The patent replaces the mechanical observation of cell growth (microscopic analysis) with molecular analysis of RNA expression profiles. Instead of visually assessing cell proliferation over time, the method uses gene expression signatures to detect genotoxic effects, enabling faster and more precise assessment without requiring prolonged cultivation periods
Solution Approach 2:
The patent changes the measurement parameter from cell growth rate (macroscopic) to RNA expression levels (molecular). By monitoring the expression levels of specific genes associated with genotoxicity, the method detects harmful effects at the molecular level before they manifest as observable changes in cell growth, thereby reducing the required assessment time while improving precision
2Loss of information
If cell growth indicators are used to assess genotoxic potential, then the assessment can be performed, but the insight provided is limited
Solution Approach 1:
The patent segments the complex genotoxicity assessment into analysis of specific RNA expression profiles of genes known to be responsive to genotoxic damage. Rather than attempting to measure all possible cellular changes, the method focuses on a targeted set of molecular indicators, providing detailed insight into genotoxic mechanisms while maintaining analytical manageability
Solution Approach 2:
The patent introduces RNA expression analysis as an intermediary between the genotoxic agent and the final assessment outcome. The RNA profiles serve as molecular mediators that translate the effects of genotoxic agents into quantifiable data, providing comprehensive insight into the nature and extent of genotoxic damage without requiring direct observation of complex cellular transformations
3Reliability
If prolonged cell proliferation is used for assessment, then transformation can be detected, but the method requires extended cultivation time and microscopic analysis
Solution Approach 1:
The patent performs preliminary detection of genotoxic effects by analyzing RNA expression profiles early in the cultivation period, before full cellular transformation occurs. By identifying molecular signatures of genotoxic damage at an early stage, the method reliably detects transformation potential without requiring cells to complete the entire transformation process, thereby significantly reducing cultivation duration while maintaining detection reliability
Data Source
Figure 1
AI summary
The present invention relates to an analytical process for the assessment of the genotoxic potential, also termed mutagenic or transforming activity, of an agent in respect to hematopoietic cells. The agent can be selected from natural and synthetic chemical compounds, and preferably from heterologous expression cassettes, e.g. contained in non-natural viral particles or non-natural viral nucleic acid constructs, e.g. nucleic acid constructs containing a viral element.